Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. Big news this morning, so let’s get straight into it.
Here they are: the first Medicare-negotiated drug prices
Medicare this morning unveiled the results of the its first round of drug price bargaining. Here’s the list of negotiated prices for a 30-day supply that will start in 2026, and their discount from the 2023 list prices:
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in